• BioNTech's Richardson on Drug Pipeline

  • Oct 3 2024
  • Length: 38 mins
  • Podcast

BioNTech's Richardson on Drug Pipeline

Listen for free

View show details

  • Summary

  • BioNTech has a broad and diversified cancer drug pipeline extending well beyond mRNA based approaches. Sam Fazeli, Senior Health Care Analyst, speaks to Ryan Richardson, Chief Strategy Officer, who explains the company’s approach to drug development, hopes for drug launches and what sets it apart from rivals.

    See omnystudio.com/listener for privacy information.
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about BioNTech's Richardson on Drug Pipeline

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available